As we come into cold and flu season, many of us will be hit by a virus once, twice or even more.This post was originally published on this site
When choosing an embryo for implantation during in vitro fertilization (IVF), would you consider its chances of developing a health condition? What about traits like creativity, intelligence, or physical fitness?This post was originally published on […]
An AI tool that analyzes nurses’ data and notes detected when patients in the hospital were deteriorating nearly two days earlier than traditional methods and reduced the risk of death by over 35%, found a […]
Recent guidelines have restricted aspirin use in the primary prevention of cardiovascular disease. The American Heart Association (AHA)/American College of Cardiology (ACC) guidelines restricted aspirin to patients under 70, and more recently, the United States […]
Ever asked a question and been met with a blank stare? It’s awkward enough with a person—but on a humanoid robot, it can be downright unsettling. Now, an international team co-led by Hiroshima University and […]
There is an urgent need for precision immunotherapy strategies that simultaneously target both tumor cells and immune cells to enhance treatment efficacy. Identifying genes with dual functions in both cancer and immune cells opens new […]
Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous tumor.This post was originally published […]
Growing up in Spain, Cecilia Huertas Cerdeira was captivated by the elegant movements of aquatic life during frequent vacations to the Atlantic coast. Later, as a doctoral student at the California Institute of Technology, she […]
Researchers with City of Hope and Memorial Sloan Kettering (MSK) Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient’s likely response to chimeric antigen receptor (CAR) T […]
Despite decades of research to develop effective treatments, the median survival for glioblastoma—the most common malignant primary brain tumor in adults—is just 15–18 months after diagnosis. One reason for this grim statistic is that these […]
© 2024 E-RADIO.CA - CANADA'S LATEST TECH NEWS HEADLINES, STORIES AND MORE.